With this little drop , Solbec , the only oncology drug developer in this country to show multiple objective responses against late stage 4 cancers , and as a stand alone agent , is now the lowest price oncology drug on the board . Who said we are the clever country ???????
I could be wrong re the actual documented performance of other cancer drug companies , so please correct me if that is so . Although Solbecs was only a phase 1 trial , feel free to quote phase 1, 2 or 3 results . That is a better than 16% OBJECTIVE(>50% tumour reduction) response against any stage 4 cancer .
Cheers
- Forums
- ASX - By Stock
- SBP
- price
SBP
solbec pharmaceuticals limited
price
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online